Skip to main content
. 2010 Oct 15;9(20):4153–4163. doi: 10.4161/cc.9.20.13454

Figure 6.

Figure 6

Candidate markers for targeted therapy. (A) Human breast cancer cell lines were treated with 500 nM PD-0332991 or DMSO control for 24 hours. Percentage BrdU positive (of total) is shown. (B) Human breast cancer cell lines were treated with 500 nM PD-0332991 or DMSO control for 24 hours. Cell lysates were subjected to immunoblot analysis for indicated proteins. (C) Relapse-free survival curves for breast cancer populations stratified by individual gene transcript levels.